ETAP-lab

ETAP-Lab is a well-established, independent preclinical CRO based in Dijon, France, with over three decades of experience. It offers a comprehensive suite of validated and customizable in vitro and in vivo disease models, emphasizing translational value and integrating chronobiology and natural behaviors. The company serves pharmaceutical, biotech, and agro-food clients, supporting drug and nutraceutical development from early discovery through preclinical phases with a strong commitment to quality, ethics, and scientific rigor.

Integrated preclinical research platforms featuring validated and customizable in vitro & in vivo disease models. Specializes in incorporating chronobiology and natural behavioral analysis to enhance translational value. Platforms include advanced in vivo imaging, behavioral assessment, and biological analysis tailored for neurology, neurovascular, cardiology, and dermatology research.

ETAP-Lab competes in the fragmented preclinical CRO market against large, full-service global players (e.g., Charles River Laboratories, Labcorp) and numerous smaller, specialized CROs. Its key differentiators are its deep expertise in ethology-informed models, high degree of model customization, and dual-sector focus on pharma and nutraceuticals. Competition is based on scientific reputation, model translational value, quality, price, and turnaround time.